- Report
- January 2024
- 200 Pages
Global
From €4753EUR$5,000USD£4,077GBP
- Report
- December 2023
- 200 Pages
Global
From €4753EUR$5,000USD£4,077GBP
- Report
- December 2023
- 200 Pages
Global
From €4753EUR$5,000USD£4,077GBP
- Report
- November 2023
- 175 Pages
Global
From €4753EUR$5,000USD£4,077GBP
- Report
- January 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,955GBP
- Report
- January 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,955GBP
- Report
- January 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,955GBP
- Report
- January 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,955GBP
- Report
- November 2023
- 150 Pages
Global
From €4611EUR$4,850USD£3,955GBP
- Report
- October 2023
- 150 Pages
Global
From €4611EUR$4,850USD£3,955GBP
- Report
- March 2024
- 194 Pages
Global
From €3208EUR$3,374USD£2,751GBP
€3564EUR$3,749USD£3,057GBP
- Report
- March 2024
- 189 Pages
Global
From €3208EUR$3,374USD£2,751GBP
€3564EUR$3,749USD£3,057GBP
- Report
- March 2024
- 181 Pages
Global
From €3208EUR$3,374USD£2,751GBP
€3564EUR$3,749USD£3,057GBP
- Report
- May 2024
- 192 Pages
Global
From €3208EUR$3,374USD£2,751GBP
€3564EUR$3,749USD£3,057GBP
- Report
- May 2024
- 188 Pages
Global
From €3208EUR$3,374USD£2,751GBP
€3564EUR$3,749USD£3,057GBP
- Report
- March 2024
- 198 Pages
Global
From €3208EUR$3,374USD£2,751GBP
€3564EUR$3,749USD£3,057GBP
- Report
- March 2024
- 188 Pages
Global
From €3208EUR$3,374USD£2,751GBP
€3564EUR$3,749USD£3,057GBP
- Report
- April 2024
- 136 Pages
Global
From €3707EUR$3,899USD£3,179GBP
- Report
- March 2024
- 139 Pages
Global
From €3707EUR$3,899USD£3,179GBP
- Report
- March 2024
- 148 Pages
Global
From €3707EUR$3,899USD£3,179GBP
The Endocrine and Metabolic Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat endocrine and metabolic disorders. Endocrine disorders are conditions that affect the body's hormones, while metabolic disorders are conditions that affect the body's ability to process and use energy. Endocrine and metabolic disorders can include diabetes, thyroid disorders, obesity, and adrenal disorders.
Endocrine and Metabolic Disorders Drugs are typically developed by pharmaceutical companies and are prescribed by physicians. These drugs can be used to treat a variety of endocrine and metabolic disorders, including diabetes, thyroid disorders, obesity, and adrenal disorders. Common drugs used to treat these conditions include insulin, metformin, and glucagon-like peptide-1 (GLP-1) agonists.
Some of the major companies in the Endocrine and Metabolic Disorders Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the development, production, and marketing of drugs used to treat endocrine and metabolic disorders. Show Less Read more